Diabetes: preventing coronary heart disease in a high risk group

被引：11

作者：

Feher, MD ^{[1
]}

机构：

[1] Chelsea & Westminster Hosp, Beta Cell Diabet Ctr, London SW10 9NH, England

来源：

HEART | 2004年 / 90卷

关键词：

D O I：

10.1136/hrt.2004.037572

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease is the major cause of morbidity and mortality in patients with type 2 diabetes. Numerous outcome trials have demonstrated clinical benefits from effective treatment of individual cardiovascular risk factors in patients with diabetes. These trials have provided the basis for current treatment guidelines and targets. More recently, multifactorial intervention strategies have shown a reduction in both cardiovascular and microvascular events in patients with type 2 diabetes. However, full implementation of a truly multifactorial strategy into routine practice remains an ideal due to practical difficulties of sustained implementation and associated costs. These practical issues relating to the treatment of diabetes and its complications are now in a greater spotlight due to the growing number of patients requiring treatment.

引用

页码：18 / 21

页数：4

共 25 条

[21]

Tonkin A, 1998, NEW ENGL J MED, V339, P1349

[22] Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. [J].

Tuomilehto, J ;

Lindström, J ;

Eriksson, JG ;

Valle, TT ;

Hamalainen, H ;

Ilanne-Parikka, P ;

Keinanen-Kiukaanniemi, S ;

Laakso, M ;

Louheranta, A ;

Rastas, M ;

Salminen, V ;

Uusitupa, M ;

Aunola, S ;

Cepaitis, Z ;

Moltchanov, V ;

Hakumaki, M ;

Mannelin, M ;

Martikkala, V ;

Sundvall, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1343-1350

[23] Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:: United kingdom prospective diabetes study (UKPDS:23) [J].

Turner, RC ;

Millns, H ;

Neil, HAW ;

Stratton, IM ;

Manley, SE ;

Matthews, DR ;

Holman, RR .

BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7134) :823-828

[24] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].

Turner, RC ;

Holman, RR ;

Stratton, IM ;

Cull, CA ;

Matthews, DR ;

Manley, SE ;

Frighi, V ;

Wright, D ;

Neil, A ;

Kohner, E ;

McElroy, H ;

Fox, C ;

Hadden, D .

LANCET, 1998, 352 (9131) :854-865

[25] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].

Turner, RC ;

Holman, RR ;

Cull, CA ;

Stratton, IM ;

Matthews, DR ;

Frighi, V ;

Manley, SE ;

Neil, A ;

McElroy, K ;

Wright, D ;

Kohner, E ;

Fox, C ;

Hadden, D ;

Mehta, Z ;

Smith, A ;

Nugent, Z ;

Peto, R ;

Adlel, AI ;

Mann, JI ;

Bassett, PA ;

Oakes, SF ;

Dornan, TL ;

Aldington, S ;

Lipinski, H ;

Collum, R ;

Harrison, K ;

MacIntyre, C ;

Skinner, S ;

Mortemore, A ;

Nelson, D ;

Cockley, S ;

Levien, S ;

Bodsworth, L ;

Willox, R ;

Biggs, T ;

Dove, S ;

Beattie, E ;

Gradwell, M ;

Staples, S ;

Lam, R ;

Taylor, F ;

Leung, L ;

Carter, RD ;

Brownlee, SM ;

Fisher, KE ;

Islam, K ;

Jelfs, R ;

Williams, PA ;

Williams, FA ;

Sutton, PJ .

LANCET, 1998, 352 (9131) :837-853

← 1 2 3 →